Swanhill Capital

Swanhill Capital LLC operates as a dedicated investment partnership, primarily focused on healthcare companies, consciously excluding the life science sector. The firm strategically infuses capital into businesses at all stages of their lifecycle, ranging from early-stage seed rounds to comprehensive traditional buyouts, participating as both minority and control investors. Its methodology emphasizes meticulous due diligence and a systematic approach to uncovering and extracting intrinsic value that other market participants may not readily perceive.

The firm was founded in 2007 by David Perkal, whose extensive prior experience included assisting numerous middle-market companies in securing capital. This background provided the foundational insight for establishing a firm committed to maximizing value within the healthcare industry through methodical assessment and a disciplined investment philosophy centered on long-term appreciation rather than short-term gains.

Swanhill Capital partners closely with the management teams of its portfolio companies, striving to cultivate long-term growth and consistent cash flow generation. Its vision involves fostering a culture of operational excellence and working collaboratively with leadership to formulate and implement strategies. These efforts are designed to drive top-line revenue growth, optimize cost structures, and ultimately enhance operating margins, ensuring the full potential of each investment is realized.